Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Innate Pharma SA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -75.72% vs 4.64% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -551.32% vs 86.90% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.60",
          "val2": "51.90",
          "chgp": "-75.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-57.10",
          "val2": "-17.30",
          "chgp": "-230.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.00",
          "val2": "1.60",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-49.50",
          "val2": "-7.60",
          "chgp": "-551.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,682.20%",
          "val2": "-431.80%",
          "chgp": "-425.04%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

12.60

51.90

-75.72%

Operating Profit (PBDIT) excl Other Income

-57.10

-17.30

-230.06%

Interest

0.60

0.60

Exceptional Items

2.00

1.60

25.00%

Consolidate Net Profit

-49.50

-7.60

-551.32%

Operating Profit Margin (Excl OI)

-4,682.20%

-431.80%

-425.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -75.72% vs 4.64% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -551.32% vs 86.90% in Dec 2023

All Annual Results